Optimeos is a transformative nanoparticle platform for intracellular delivery of RNActschensui2023-06-27T06:28:07+00:00 Project Description Optimeos is a transformative nanoparticle platform for intracellular delivery of RNA Project Details Categories: Commercial Project URL: View Project Copyright: Fusion-Themes Related Projects Aqualung is a Tucson, AZ and Jupiter, FL -based biotech company to provide an immune-focused biologic platform for serious inflammatory and fibrotic disorders. February 22nd, 2023 | 0 Comments BBy is revolutionizing the way hospitals manage, store and deliver breast milk to infants in the most need February 13th, 2015 | 0 Comments Curbside is delivering software that makes it easy for clinicians to consistently deliver best practice clinical care February 13th, 2015 | 0 Comments i2o Therapeutics has developed disruptive ionic liquid technology to enable oral delivery of biologics February 13th, 2015 | 0 Comments Kayothera is developing first-in-class small molecule immunotherapies to treat solid cancers February 13th, 2015 | 0 Comments